BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 24466286)

  • 1. Resurgence of persisting non-cultivable Borrelia burgdorferi following antibiotic treatment in mice.
    Hodzic E; Imai D; Feng S; Barthold SW
    PLoS One; 2014; 9(1):e86907. PubMed ID: 24466286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistence of Borrelia burgdorferi following antibiotic treatment in mice.
    Hodzic E; Feng S; Holden K; Freet KJ; Barthold SW
    Antimicrob Agents Chemother; 2008 May; 52(5):1728-36. PubMed ID: 18316520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lyme Borreliosis: Is there a preexisting (natural) variation in antimicrobial susceptibility among Borrelia burgdorferi strains?
    Hodzic E
    Bosn J Basic Med Sci; 2015 Jul; 15(3):1-13. PubMed ID: 26295288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ineffectiveness of tigecycline against persistent Borrelia burgdorferi.
    Barthold SW; Hodzic E; Imai DM; Feng S; Yang X; Luft BJ
    Antimicrob Agents Chemother; 2010 Feb; 54(2):643-51. PubMed ID: 19995919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generality of Post-Antimicrobial Treatment Persistence of
    Hodzic E; Imai DM; Escobar E
    Infect Immun; 2019 Oct; 87(10):. PubMed ID: 31308087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of attenuated, noninfectious spirochetes in Borrelia burgdorferi-infected mice after antibiotic treatment.
    Bockenstedt LK; Mao J; Hodzic E; Barthold SW; Fish D
    J Infect Dis; 2002 Nov; 186(10):1430-7. PubMed ID: 12404158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence of Borrelia burgdorferi in rhesus macaques following antibiotic treatment of disseminated infection.
    Embers ME; Barthold SW; Borda JT; Bowers L; Doyle L; Hodzic E; Jacobs MB; Hasenkampf NR; Martin DS; Narasimhan S; Phillippi-Falkenstein KM; Purcell JE; Ratterree MS; Philipp MT
    PLoS One; 2012; 7(1):e29914. PubMed ID: 22253822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-tumor necrosis factor-alpha activation of Borrelia burgdorferi spirochetes in antibiotic-treated murine Lyme borreliosis: an unproven conclusion.
    Wormser GP; Barthold SW; Shapiro ED; Dattwyler RJ; Bakken JS; Steere AC; Bockenstedt LK; Radolf JD
    J Infect Dis; 2007 Dec; 196(12):1865-6; author reply 1866-7. PubMed ID: 18190269
    [No Abstract]   [Full Text] [Related]  

  • 9. Culture of the entire mouse to determine whether cultivable Borrelia burgdorferi persists in infected mice treated with a five-day course of Ceftriaxone.
    Pavia CS; Wormser GP
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6701-3. PubMed ID: 25155590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spirochete antigens persist near cartilage after murine Lyme borreliosis therapy.
    Bockenstedt LK; Gonzalez DG; Haberman AM; Belperron AA
    J Clin Invest; 2012 Jul; 122(7):2652-60. PubMed ID: 22728937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decorin binding proteins of Borrelia burgdorferi promote arthritis development and joint specific post-treatment DNA persistence in mice.
    Salo J; Jaatinen A; Söderström M; Viljanen MK; Hytönen J
    PLoS One; 2015; 10(3):e0121512. PubMed ID: 25816291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-tumor necrosis factor-alpha treatment activates Borrelia burgdorferi spirochetes 4 weeks after ceftriaxone treatment in C3H/He mice.
    Yrjänäinen H; Hytönen J; Song XY; Oksi J; Hartiala K; Viljanen MK
    J Infect Dis; 2007 May; 195(10):1489-96. PubMed ID: 17436229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence of borrelial DNA in the joints of Borrelia burgdorferi-infected mice after ceftriaxone treatment.
    Yrjänäinen H; Hytönen J; Hartiala P; Oksi J; Viljanen MK
    APMIS; 2010 Sep; 118(9):665-73. PubMed ID: 20718718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heritable susceptibility to severe Borrelia burgdorferi-induced arthritis is dominant and is associated with persistence of large numbers of spirochetes in tissues.
    Yang L; Weis JH; Eichwald E; Kolbert CP; Persing DH; Weis JJ
    Infect Immun; 1994 Feb; 62(2):492-500. PubMed ID: 8300208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of Borrelia burgdorferi nucleic acids after antibiotic treatment does not confirm viability.
    Iyer R; Mukherjee P; Wang K; Simons J; Wormser GP; Schwartz I
    J Clin Microbiol; 2013 Mar; 51(3):857-62. PubMed ID: 23269733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of transcriptional activity of Borrelia burgdorferi and host cytokine genes during early and late infection in a mouse model.
    Hodzic E; Feng S; Barthold SW
    Vector Borne Zoonotic Dis; 2013 Oct; 13(10):694-711. PubMed ID: 23930938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying Vancomycin as an Effective Antibiotic for Killing Borrelia burgdorferi.
    Wu X; Sharma B; Niles S; O'Connor K; Schilling R; Matluck N; D'Onofrio A; Hu LT; Lewis K
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126963
    [No Abstract]   [Full Text] [Related]  

  • 18. Fate of Borrelia burgdorferi DNA in tissues of infected mice after antibiotic treatment.
    Malawista SE; Barthold SW; Persing DH
    J Infect Dis; 1994 Nov; 170(5):1312-6. PubMed ID: 7963735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting of vascular adhesion protein-1 by positron emission tomography visualizes sites of inflammation in Borrelia burgdorferi-infected mice.
    Siitonen R; Pietikäinen A; Liljenbäck H; Käkelä M; Söderström M; Jalkanen S; Hytönen J; Roivainen A
    Arthritis Res Ther; 2017 Nov; 19(1):254. PubMed ID: 29166944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo activities of ceftriaxone and vancomycin against Borrelia spp. in the mouse brain and other sites.
    Kazragis RJ; Dever LL; Jorgensen JH; Barbour AG
    Antimicrob Agents Chemother; 1996 Nov; 40(11):2632-6. PubMed ID: 8913478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.